Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 57, 4455-4459, October 15, 1997]
© 1997 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Correction (v57,p5613)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voeller, H. J.
Right arrow Articles by Gelmann, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voeller, H. J.
Right arrow Articles by Gelmann, E. P.

Coding Region of NKX3.1, a Prostate-Specific Homeobox Gene on 8p21, Is Not Mutated in Human Prostate Cancers1

H. James Voeller, Meena Augustus2, Victor Madike2, G. Steven Bova, Kenneth C. Carter and Edward P. Gelmann3

Division of Hematology/Oncology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007-2197 [H. J. V., E. P. G.]; Department of Molecular Biology, Human Genome Sciences Inc., Rockville, Maryland 20850 [M. A., V. M., K. C. C.]; and Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland 21287 [G. S. B.]

Loss of heterozygosity at chromosome 8p21–22 is common in human prostate cancer, suggesting the presence of one or more tumor suppressor genes at this locus. A homeobox gene that is expressed specifically in adult human prostate, NKX3.1, the expression of which is regulated by androgen, maps to chromosome 8p21. Fine structure in situ mapping showed that NKX3.1 is proximal to MSR32 (macrophage scavenge scavenger receptor type II) and LPL (human lipoprotein lipase) and very close to NEFL (human neurofilament light chain) on 8p21. Single-strand conformational polynorphism analysis of 48 radical prostatectomy cancer specimens and 3 metastases for the entire coding region of NKX3.1 showed no tumorspecific sequence alterations in 50 specimens and total absence of the gene in 1 specimen known to have a biallelic deletion of 8p21. NKX3.1 was found to have a polymorphism at nucleotide 154 in codon 52 that resulted in a CGC->TGC sequence change and an Arg->Cys amino acid alteration (R52C). This polymorphism was present in 20% of DNA smaples. If NKX3.1 is a target of the 8p21 LOH, it is not via disruption of the coding region of the gene.

1 This work was supported by NIH Grant CA57178 to E.P.G. and by an award from the CaPCURE Foundation.

2 These authors contributed equally to this work.

3 To whom requests for reprints should be addressed, at Division of Hematology/Oncology, Lombardi Cancer Center, Georgetown University Medical Centcer, 3800 Reservoir Road NW, Washsington, DC 20007-2197. Phone: (202) 687-2207; Fax: (202) 784-1229; E-mail: gelmanne@gunet.georgetown.edu.

Received 6/26/97. Accepted 8/28/97.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
B. Guan, P. Pungaliya, X. Li, C. Uquillas, L. N. Mutton, E. H. Rubin, and C. J. Bieberich
Ubiquitination by TOPORS Regulates the Prostate Tumor Suppressor NKX3.1
J. Biol. Chem., February 22, 2008; 283(8): 4834 - 4840.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann
NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity
Cancer Res., January 15, 2007; 67(2): 455 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. R. Bethel, D. Faith, X. Li, B. Guan, J. L. Hicks, F. Lan, R. B. Jenkins, C. J. Bieberich, and A. M. De Marzo
Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion.
Cancer Res., November 15, 2006; 66(22): 10683 - 10690.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Gao, X. Ouyang, W. A. Banach-Petrosky, M. M. Shen, and C. Abate-Shen
Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in Nkx3.1; Pten Mice
Cancer Res., August 15, 2006; 66(16): 7929 - 7933.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
X. Li, B. Guan, S. Maghami, and C. J. Bieberich
NKX3.1 Is Regulated by Protein Kinase CK2 in Prostate Tumor Cells
Mol. Cell. Biol., April 15, 2006; 26(8): 3008 - 3017.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
L. Zhang and G. J Barritt
TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?
Endocr. Relat. Cancer, March 1, 2006; 13(1): 27 - 38.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Zheng, J.-h. Ju, B.-l. Chang, E. Ortner, J. Sun, S. D. Isaacs, J. Sun, K. E. Wiley, W. Liu, M. Zemedkun, et al.
Germ-Line Mutation of NKX3.1 Cosegregates with Hereditary Prostate Cancer and Alters the Homeodomain Structure and Function
Cancer Res., January 1, 2006; 66(1): 69 - 77.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. R. Payne and C. J. Kemp
Tumor suppressor genetics
Carcinogenesis, December 1, 2005; 26(12): 2031 - 2045.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. S. Palapattu, S. Sutcliffe, P. J. Bastian, E. A. Platz, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson
Prostate carcinogenesis and inflammation: emerging insights
Carcinogenesis, July 1, 2005; 26(7): 1170 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Asatiani, W.-X. Huang, A. Wang, E. Rodriguez Ortner, L. R. Cavalli, B. R. Haddad, and E. P. Gelmann
Deletion, Methylation, and Expression of the NKX3.1 Suppressor Gene in Primary Human Prostate Cancer
Cancer Res., February 15, 2005; 65(4): 1164 - 1173.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. A. Maddison, B. W. Sutherland, R. J. Barrios, and N. M. Greenberg
Conditional Deletion of Rb Causes Early Stage Prostate Cancer
Cancer Res., September 1, 2004; 64(17): 6018 - 6025.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. I. Skotheim, K. S. Korkmaz, T. I. Klokk, V. M. Abeler, C. G. Korkmaz, J. M. Nesland, S. D. Fossa, R. A. Lothe, and F. Saatcioglu
NKX3.1 Expression Is Lost in Testicular Germ Cell Tumors
Am. J. Pathol., December 1, 2003; 163(6): 2149 - 2154.
[Abstract] [Full Text]

Home page
 NEJMHome page
W. G. Nelson, A. M. De Marzo, and W. B. Isaacs
Prostate Cancer
N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Abate-Shen, W. A. Banach-Petrosky, X. Sun, K. D. Economides, N. Desai, J. P. Gregg, A. D. Borowsky, R. D. Cardiff, and M. M. Shen
Nkx3.1; Pten Mutant Mice Develop Invasive Prostate Adenocarcinoma and Lymph Node Metastases
Cancer Res., July 15, 2003; 63(14): 3886 - 3890.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Kim, R. Bhatia-Gaur, W. A. Banach-Petrosky, N. Desai, Y. Wang, S. W. Hayward, G. R. Cunha, R. D. Cardiff, M. M. Shen, and C. Abate-Shen
Nkx3.1 Mutant Mice Recapitulate Early Stages of Prostate Carcinogenesis
Cancer Res., June 1, 2002; 62(11): 2999 - 3004.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. P. Gelmann, D. J. Steadman, J. Ma, N. Ahronovitz, H. J. Voeller, S. Swope, M. Abbaszadegan, K. M. Brown, K. Strand, R. B. Hayes, et al.
Occurrence of NKX3.1 C154T Polymorphism in Men with and without Prostate Cancer and Studies of Its Effect on Protein Function
Cancer Res., May 1, 2002; 62(9): 2654 - 2659.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. A. Abdulkadir, J. A. Magee, T. J. Peters, Z. Kaleem, C. K. Naughton, P. A. Humphrey, and J. Milbrandt
Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia
Mol. Cell. Biol., March 1, 2002; 22(5): 1495 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. J. Kim, R. D. Cardiff, N. Desai, W. A. Banach-Petrosky, R. Parsons, M. M. Shen, and C. Abate-Shen
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
PNAS, February 14, 2002; (2002) 42688999.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. B. Martin, H. J. Voeller, E. P. Gelmann, J. Lu, E.-G. Stoica, E. J. Hebert, R. Reiter, B. Singh, M. Danielsen, E. Pentecost, et al.
Role of Cadmium in the Regulation of AR Gene Expression and Activity
Endocrinology, January 1, 2002; 143(1): 263 - 275.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Chen, A. K. Nandi, X. Li, and C. J. Bieberich
NKX-3.1 Interacts with Prostate-derived Ets Factor and Regulates the Activity of the PSA Promoter
Cancer Res., January 1, 2002; 62(2): 338 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Bowen, L. Bubendorf, H. J. Voeller, R. Slack, N. Willi, G. Sauter, T. C. Gasser, P. Koivisto, E. E. Lack, J. Kononen, et al.
Loss of NKX3.1 Expression in Human Prostate Cancers Correlates with Tumor Progression1,2
Cancer Res., November 1, 2000; 60(21): 6111 - 6115.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
C. Abate-Shen and M. M. Shen
Molecular genetics of prostate cancer
Genes & Dev., October 1, 2000; 14(19): 2410 - 2434.
[Full Text]

Home page
 Nucleic Acids ResHome page
D. J. Steadman, D. Giuffrida, and E. P. Gelmann
DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1
Nucleic Acids Res., June 15, 2000; 28(12): 2389 - 2395.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
R. Bhatia-Gaur, A. A. Donjacour, P. J. Sciavolino, M. Kim, N. Desai, P. Young, C. R. Norton, T. Gridley, R. D. Cardiff, G. R. Cunha, et al.
Roles for Nkx3.1 in prostate development and cancer
Genes & Dev., April 15, 1999; 13(8): 966 - 977.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. J. Kim, R. D. Cardiff, N. Desai, W. A. Banach-Petrosky, R. Parsons, M. M. Shen, and C. Abate-Shen
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
PNAS, March 5, 2002; 99(5): 2884 - 2889.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.